Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Acquisitions (2016 - 2019)

Historic Acquisitions for Pharma (IGC) over the last 9 years, with Q3 2019 value amounting to $19000.0.

  • Pharma's Acquisitions rose 13750.0% to $19000.0 in Q3 2019 from the same period last year, while for Sep 2019 it was $55000.0, marking a year-over-year increase of 19322.03%. This contributed to the annual value of $45000.0 for FY2019, which is 3076.92% down from last year.
  • Pharma's Acquisitions amounted to $19000.0 in Q3 2019, which was up 13750.0% from $4000.0 recorded in Q2 2019.
  • In the past 5 years, Pharma's Acquisitions ranged from a high of $149000.0 in Q4 2017 and a low of -$221000.0 during Q1 2018
  • For the 5-year period, Pharma's Acquisitions averaged around $146.17, with its median value being $4500.0 (2018).
  • Its Acquisitions has fluctuated over the past 5 years, first crashed by 386256.04% in 2016, then soared by 13750.0% in 2019.
  • Over the past 5 years, Pharma's Acquisitions (Quarter) stood at -$414.0 in 2015, then plummeted by 3862.56% to -$16405.0 in 2016, then skyrocketed by 1008.26% to $149000.0 in 2017, then tumbled by 80.54% to $29000.0 in 2018, then crashed by 34.48% to $19000.0 in 2019.
  • Its Acquisitions stands at $19000.0 for Q3 2019, versus $4000.0 for Q2 2019 and $3000.0 for Q1 2019.